Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Survival outcomes with trastuzumab deruxtecan in HER2-positive vs. HER2-low breast cancer patients with brain metastases: a real-world cohort study

PaperCitations, authors & open-access status

Survival outcomes with trastuzumab deruxtecan in HER2-positive vs. HER2-low breast cancer patients with brain metastases: a real-world cohort study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 0 citations, 2026 year and gold oa status.

0
Citations
2026
Year
gold
OA Status

Related on ScholarIQ

Lydia Hodgson
Author
Scientific Reports
Journal
Brain Metastases and Treatment
Topic
Brain Metastases and Treatment
Topic
HER2/EGFR in Cancer Research
Topic
Lung Cancer Research Studies
Topic
470M+ articles · free account